1. Access to medications for opioid use disorder for formerly incarcerated individuals during community reentry: a mini narrative review;Frontiers in Public Health;2024-05-13

2. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-09

3. The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State;Addiction Science & Clinical Practice;2022-07-07

4. Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada;International Journal of Qualitative Studies on Health and Well-being;2022-07-05

5. Opioid agonist treatment is highly protective against overdose death among a U.S. statewide population of justice-involved adults;The American Journal of Drug and Alcohol Abuse;2020-10-29